Heidelberg Postdoc Symposium / DKTK YAC 2025

Details for Julia Stingl

Title: Prof.

Affiliation: Heidelberg University Hospital

Author in the following contribution

• Pharmacological inhibition of the Hsf1 pathway as a potential strategy for treating glioblastoma